Fate Therapeutics (FATE) Net Margin Growth (3y) (2015 - 2026)
Fate Therapeutics (FATE) Net Margin Growth (3y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
49,253.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
506.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Fate Therapeutics |
250.86 Mn |
250.86 Mn |
- |
-235,448.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-235,448.00 |
| Dec 31, 2025 |
-223,533.00 |
| Sep 30, 2025 |
-128,247.00 |
| Jun 30, 2025 |
-134,140.00 |
| Mar 31, 2025 |
-192,715.00 |
| Dec 31, 2024 |
-270,677.00 |
| Sep 30, 2024 |
-117,754.00 |
| Jun 30, 2024 |
-24,824.00 |
| Mar 31, 2024 |
-202,600.00 |
| Dec 31, 2023 |
-239,714.00 |
| Sep 30, 2023 |
-198,550.00 |
| Jun 30, 2023 |
-572,256.00 |
| Mar 31, 2023 |
129,059.00 |
| Dec 31, 2022 |
87,354.00 |
| Sep 30, 2022 |
53,073.00 |
| Jun 30, 2022 |
38,915.00 |
| Mar 31, 2022 |
34,863.00 |
| Dec 31, 2021 |
56,016.00 |
| Sep 30, 2021 |
125,371.00 |
| Jun 30, 2021 |
156,752.00 |
